Meeting Minutes for Potassium Iodide Pill Working Group Teleconference

Agenda

1. Opening remarks
2. Feedback Form – Phase I workshop
3. Discuss revised draft Meeting Minutes
4. Next steps for the draft Phase I Report
5. Closing Remarks

Date

December 20, 2019

Time

10:30-11:30 am

Duration

1 hour

1. Opening remarks

The Canadian Nuclear Safety Commission (CNSC) provided opening remarks and reiterated the purpose of the meeting to discuss the draft Phase I Workshop meeting minutes, and seek concurrence on the draft minutes to move forward with translation and posting on the Working Group webpage.

CNSC also briefed Working Group members on the update to the Commission in December 2019 in which the Commission inquired about the plans in place to solicit feedback from the public on the Phase I report. CNSC sought feedback from members regarding the communication platforms and tools that could be leveraged to support the public comment period for the Phase I report. The following feedback was received:

• Some municipalities noted that due to the lack of outreach done on this topic, they raised concerns about posting the report directly on their websites and social media platforms.
• OPG indicated they could leverage preparedtobesafe.com which could be linked by other organizations.
• CNSC indicated that availability of the report can be posted to the CNSC KI Working Group webpage which could also be linked by other organizations.
• Durham indicated that a KI pill awareness campaign is scheduled for January 2020 in which a communications plan for this Working Group and the Phase I report could be integrated.
• Some members inquired about the report being made available in the nine official languages for the Toronto area. CNSC noted that as a federal requirement, the report will be made available in English and French, but agreed that this was something that should be taken into consideration for the Toronto area. It was noted this may be difficult to complete for the draft report, but can be considered further for the final report.

2. Feedback Form – Phase I workshop

Members were asked to provide feedback of the Phase I Workshop to help identify what went well, topic areas to discuss further, and any improvements that could be made for the next workshop. Members were encouraged to provide feedback using the feedback form that was sent on December 13, 2019.

3. Discuss revised draft Meeting Minutes

CNSC went over the comments received for the Phase I Workshop meeting minutes and detailed the revisions made to address the comments. Overall there were no concerns raised over the disposition of comments and the revision of the meeting minutes. CNSC sought feedback on whether all members concurred with the content of the meeting minutes in which no members raised any comments or concerns.

CNSC indicated they will recirculate the final version of the meeting minutes to all members. Should any concerns be identified, members are encouraged to submit comments as soon as possible so they can be addressed quickly and the translated version updated prior to posting.

4. Next steps for the draft Phase I Report

CNSC indicated that they are incorporating the information from the Phase I Workshop into the Phase I report. Once complete, CNSC will distribute the newest revision of the Phase I draft report to the Working Group members for feedback and comments. CNSC emphasized that feedback should clearly indicate any issues or concerns that may delay posting the report for public review. CNSC noted that there will be opportunities before, during and after the public review for members to provide additional comments and feedback on the Phase I report.

5. Closing Remarks

CNSC thanked all the Working Group members for their participation in the teleconference and their ongoing support to the overall KI Pill Working Group.

The following actions were identified: